Recent studies on immunoPET imaging in GBM have demonstrated its powerful application in noninvasively visualizing and quantifying immune-related biomarkers, mainly focusing on CD8+ T cell infiltration and PD-L1 expression, to assess and predict immunotherapy response [57,58]. The gene discussed is CD8A; the disease is glioblastoma.